multiple sclerosis/мучнина

Веза се чува у привремену меморију

Чланци Клиничка испитивања Патенти

Изаберите тип сортирања

12 резултати

Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese Relapsing Multiple Sclerosis Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Study duration per participant is approximately 28 weeks including a 24-week treatment period

Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Multiple sclerosis (MS), the most prevalent neurological disability, is an autoimmune-mediated disorder that affects the central nervous system (CNS) and often leads to severe physical or cognitive incapacitation as well as neurological problems in young adults . Multifocal zones of inflammation due

Cannabis Oil for Pain in Parkinson's Disease

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND AND RATIONALE Pain is a common symptom in PD and is reported in up to 50 % of patients. Pain in PD has been classified as musculoskeletal, dystonic (particularly in OFF-periods), radicular and central pain, and is frequently associated with muscle rigidity, postural abnormalities and

Management Of Acute Disseminating Encephalomyelitis

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Acute disseminated encephalomyelitis can occur at any age, but usually affects children and young adults. The mean age of clinical presentation in pediatric cohorts ranges from 5 to 8 years. The annual incidence of Acute disseminated encephalomyelitis is reported to be 0.4-0.8 per 100,000 and the

Impact of Tecfidera on Gut Microbiota

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

This will be an open-label prospective study design with respect to MS immunomodulatory therapy choice. Study group will be defined as subjects with a relapsing form of multiple sclerosis as defined by the McDonald criteria choosing to begin dimethyl fumarate (DMF) therapy. Blinding of the principal

Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

5 Introduction Multiple System Atrophy (MSA) is a slowly progressing neurodegenerative disease that is characterized by i) a hypokinetic movement disorder which defines MSA of the parkinsonian type (MSA-P) or by ii) cerebellar symptoms which define MSA of the cerebellar type (MSA-C). In both types

Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND AND RATIONALE Multiple Sclerosis (MS) is the most common chronic neurological disease affecting young adults, with onset usually at age 20-40 years. Women are affected 3-4 times more than men. The disease is characterized by 2 main phenotypes: relapsing-remitting or progressive

Post-Operative Colonization Rates of Femoral Nerve Catheters Treated With Chlorhexidine-Impregnated Patch

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Gabapentin for Prophylaxis Intrathecal Morphine-Induced Pruritus

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

The study was approved by the ethic committee of Songklanagarind Hospital in Songkhla, Thailand, and was designed as a randomized, double-blind, placebo-controlled trial. All patients gave their informed consent after receiving written information of the study. Orthopedic patients were invited to

Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Background: Cannabis sativa contains over sixty cannabinoids, including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). CBD lacks psychoactivity and may attenuate the subjective effects produced by THC. The ratio of THC:CBD in illicit cannabis in the US is approximately 20:1.

Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

1. Current treatments for Multiple Sclerosis (MS) only partially reduce the relapse rate or improve symptoms, have to be injected, and have side effects. In animal models of MS, the FDA-approved oral anti-diabetic drug ACTOS prevented and reduced symptoms. ACTOS has a good safety profile in

Modafinil in Multiple Sclerosis

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Recent prevalence estimates of cognitive dysfunction in MS fall as high as 54-65%,21 with impairments having been documented in cognitive realms such as attention, executive control, working memory, and episodic memory. Deficits in long-term episodic memory in MS are a major complaint of patients,

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима